News - Pill Pals® - The Express Pharmacy

+1.855.816.PALS (7257) info@pillpals.co

October – December 2021 | Potential Signals of Serious Risks/New Safet

by Pill Pals | Mar 5, 2025 | News

Actemra (tocilizumab)Drug reaction with eosinophilia and systemic symptomsFDA is evaluating the need for regulatory action.Aliqopa (copanlisib)Cytomegalovirus infection The “Warnings and Precautions”, “Dosage and Administration”, and “Patient Information” sections of...

Plan, Prepare and Protect Your Pet Before, During, After an Emergency

by Pill Pals | Mar 5, 2025 | News

EspañolThey make us laugh. They are usually waiting for us when we get home from work and school. They give us unconditional love. They are often our best friends. And they depend on us for everything: food, water, healthcare. They are our pets and part of the...

An Update on Sunscreen Requirements

by Pill Pals | Mar 5, 2025 | News

FDA regulates sunscreens, which are nonprescription drugs, to help make sure that consumers have access to safe and effective sun protection products. There have been several developments involving sunscreen regulation in the past few years. Today, there are two more:...

Nova-Tech, Inc. Issues Voluntary Nationwide Recall of Lactated Ringers 5 L Injectable Solution for Veterinary Use Due to Potential Presence of Fiber-like Particles

by Pill Pals | Mar 5, 2025 | News

Summary Company Announcement Date: March 04, 2025 FDA Publish Date: March 05, 2025 Product Type: Animal & Veterinary Reason for Announcement: Recall Reason Description Potential presence of fiber-like particles. Company Name: Nova-Tech, Inc. Brand Name: Product...

Early Alert: Infusion Pump Issue from Baxter Healthcare Corporation

by Pill Pals | Mar 5, 2025 | News

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes...

Pediatric Exclusivity Granted

by Pill Pals | Mar 5, 2025 | News

Drugs to Which FDA has Granted Pediatric Exclusivity for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic ActNOTE: This list simply identifies approved active drugs with sponsors to which FDA has granted exclusivity for pediatric studies....